Neoplasia, the process of abnormal and uncontrolled cell growth, underpins cancer development and progression. This pathological proliferation results in benign or malignant tumors, with malignant neoplasms exhibiting invasive and metastatic properties. Recent cancer research focuses on elucidating the molecular mechanisms driving neoplastic transformation, including genetic mutations, epigenetic alterations, and dysregulated signaling pathways. Advances in understanding the tumor microenvironment and its role in supporting neoplastic growth have highlighted the importance of targeting not only the cancer cells but also the surrounding stromal and immune cells. Innovative therapies, such as immunotherapy, targeted treatments, and personalized medicine, are being developed to exploit these insights, aiming to improve patient outcomes and minimize adverse effects. The dynamic interplay between genetic predisposition and environmental factors continues to be a crucial area of investigation in the quest to prevent and treat neoplasia effectively.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States